Hospital Universitari Vall d'Hebron

Barcelona, Other 08035

0 studies enrolling now · 4 studies all time

What they study most

Appendiceal Adenocarcinoma, Bladder Cancer, Carcinoma, Non-Small Cell Lung, Cervical Cancer, Classical Hodgkin Lymphoma, Colorectal Neoplasms, Cutaneous Melanoma, Diffuse Large B-cell Lymphoma, Endometrial Neoplasms, Esophageal Neoplasms, Exocrine Pancreatic Adenocarcinoma, Gastric Carcinoma

Studies at this site

• Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer — Completed
• Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma — Stopped early
• A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer — Stopped early
• A Study of SGN-STNV in Advanced Solid Tumors — Stopped early